ALCAM and neoplasm: ALCAM mRNA expression did not correlate with tumor stage (Kruskal-Wallis (K-W), P = 0.722; Jonckheere-Terpstra test for trend (J-T), P = 0.610; Figure 1B), nor did it significantly stratify patient outcome of overall survival when dichotomized around the median log2 mRNA level of 10.4 (Log-rank, P = 0.325; Hazards Ratio (HR), 1.25; 95% Confidence Interval (CI), 0.75–2.07; Figure 1C).